BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38322311)

  • 1. Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report.
    Zhou Y
    Case Rep Ophthalmol; 2024; 15(1):122-128. PubMed ID: 38322311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report.
    Salehi M; Shahi F; Rizvi FS; Ghaderkhani S; Zainaldain H; Khodavaisy S; Jamali-Moghaddam SR; Dehghan Manshadi SA; Rezahosseini O
    Caspian J Intern Med; 2020; 11(2):227-230. PubMed ID: 32509254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
    Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
    Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-Orbital Cerebral Mucormycosis in a Healthy Female Child: Case Report.
    Yusuf AA; Ibrahim IG; Hirsi IM; Adali A; Hassan YY; Yasar MZ; Abdullahi IM; Hassan MS
    Int Med Case Rep J; 2024; 17():241-246. PubMed ID: 38559497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.
    Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B.
    Safi M; Ang MJ; Patel P; Silkiss RZ
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100771. PubMed ID: 32551404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India.
    Nagarkar NM; Sahu V; Arora R; Pathak M; Shambharkar MS; Naveen P
    Int Ophthalmol; 2023 Jul; 43(7):2363-2370. PubMed ID: 36645635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study.
    Dallalzadeh LO; Ediriwickrema LS; Fung SE; Men CJ; Kossler AL; Kupcha AC; Mawn LA; Burkat CN; van Landingham SW; Conger JR; Simmons B; Pham C; Akella SS; Setabutr P; Ho T; Couch SM; Kim JS; Demirci H; Korn BS; Kikkawa DO; Liu CY
    Orbit; 2024 Feb; 43(1):41-48. PubMed ID: 36880205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
    Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhino orbital cerebral mucormycosis in settings of COVID-19 infection: A case series of thirteen patients.
    Verma R; Chakraborty R; Keerthiraj DB; Pal US
    Natl J Maxillofac Surg; 2023; 14(2):311-316. PubMed ID: 37661985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal Endophthalmitis in a Case of Rhino-Orbito-Cerebral Mucormycosis: Successfully Treated With Amphotericin B Colloidal Dispersion.
    Zhao Y; Tian W; Yang J; Li X; Lu H; Yu N; Zhang P; Liu C; Chen P; Lei G; Liu Y
    Front Microbiol; 2022; 13():910419. PubMed ID: 35783387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.
    Mrig S; Sardana K; Arora P; Narula V; Arora S; Kapoor A; Baruah RR; Sen P; Agarwal S; Sachdeva S; Dewan A; Panesar S
    Am J Otolaryngol; 2022; 43(3):103465. PubMed ID: 35429848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival from Rhino-Orbital-Cerebral Mucormycosis in SARS-CoV-2-Positive Diabetic Patients: Two Case Reports.
    Lädrach C; Wartenberg M; Zimmerli S; Anschuetz L; Bohlen S; Ebner J; de Gouyon Matignon de Pontouraude CMF; Caversaccio M; Wagner F
    Case Rep Neurol; 2024; 16(1):89-98. PubMed ID: 38690082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.